Fibrinogen Saint-Germain I: A case of the heterozygous Aα GLY 12 → VAL fibrinogen variant

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 2, 2002, Pages 149-153

  Mathonnet, F ^a   Peltier, J Y ^a   Detruit, H ^a   De Raucourt, E ^a   Alvarez, J C ^a   Mazmanian, G M ^a   De Mazancourt, Philippe ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Dysfibrinogen; Factor V; Fibrinogen; Fibrinopeptide; Mutation

Indexed keywords

DNA; FIBRINOGEN; FIBRINOPEPTIDE; GLYCEROL; THROMBIN; VALINE; FIBRINOGEN SAINT GERMAIN I; FIBRINOGEN SAINT-GERMAIN I; FIBRINOGEN VARIANT; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B;

ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CASE REPORT; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HETEROZYGOSITY; HUMAN; IMMUNOASSAY; KINETICS; POLYMERIZATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN SECRETION; AMINO ACID SUBSTITUTION; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; DIFFERENTIAL DIAGNOSIS; FAMILY HEALTH; GENETIC VARIABILITY; GENETICS; HETEROZYGOTE; NUCLEOTIDE SEQUENCE; POINT MUTATION;

AMINO ACID SUBSTITUTION; CHILD, PRESCHOOL; COAGULATION PROTEIN DISORDERS; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FACTOR V DEFICIENCY; FAMILY HEALTH; FEMALE; FIBRINOGENS, ABNORMAL; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; HETEROZYGOTE; HUMANS; POINT MUTATION; VARIATION (GENETICS);

EID: 0036489728     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200203000-00010     Document Type: Article

References (18)

1. Dysfibrinogenemia and other disorders of fibrinogen structure and function
2. Familial dysfibrinogenemia thrombophilia. Report on a study of the SCC subcomittee on fibrinogen
3. High-resolution NMR studies of fibrinogen-like peptides in solution: Structural basis for the bleeding disorder caused by a single mutation of Gly(12) to VAL(12) in the Aα chain of human fibrinogen Rouen
4. Congenital dysfibrinogenemia: Fibrinogen Lille
5. Analysis of human fibrinopeptides by high-performance liquid chromatography
6. Fibrinogen-fibrin interaction
7. Three new cases of dysfibrinogemia: Poissy III, St-Germain I and Tahiti
8. Mutation in blood coagulation factor V associated with resistance to activated protein C
9. An improved method for the detection of the G20210A transition in the prothrombin gene
10. An improved method for the detection of the thermolabile variant of methylenetetra-hydrofolate reductase
11. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: A new structural basis for thrombin specificity
12. Genetically abnormal fibrinogens - Some current characterization strategies
13. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin
14. Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations
15. The fibrinogen sequences that interact with thrombin
16. Fibrinogen Mitaka II: A hereditary dysfibrinogen with defective thrombin binding caused by an AαGlu-11 to Gly substitution
17. Coagulation cofactors: Factors V and VIII